Works matching IS 00071188 AND DT 2017 AND VI 174 AND IP 22
Results: 28
The novel, potent and highly selective 5-HT<sub>4</sub> receptor agonist YH12852 significantly improves both upper and lower gastrointestinal motility.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Up-regulation of PYK2/PKCα-dependent haem oxygenase-1 by CO-releasing molecule-2 attenuates TNF-α-induced lung inflammation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Response to 'Effects of diesel exhaust particles on coagulation'.
- Published in:
- 2017
- By:
- Publication type:
- Letter
PDE1A inhibition elicits cGMP-dependent relaxation of rat mesenteric arteries.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Targeting inflammation to reduce cardiovascular disease risk.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol.
- Published in:
- 2017
- By:
- Publication type:
- journal article
T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Proteinase activated receptor-2 counterbalances the vascular effects of endothelin-1 in fibrotic tight-skin mice.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.
- Published in:
- British Journal of Pharmacology, 2017, v. 174, n. 22, p. 4007, doi. 10.1111/bph.13619
- By:
- Publication type:
- Article
Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia-induced pulmonary hypertension.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effects of diesel exhaust particles on coagulation.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E<sup>-/-</sup> mice.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rapid vasodilation to raloxifene: role of oestrogen receptors and off-target effects.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Widespread brain distribution and activity following i.c.v. infusion of anti-β-secretase (BACE1) in nonhuman primates.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Issue Information.
- Published in:
- British Journal of Pharmacology, 2017, v. 174, n. 22, p. 3893, doi. 10.1111/bph.13605
- Publication type:
- Article
The role of 5-HT<sub>2B</sub> receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rubiarbonone C inhibits platelet-derived growth factor-induced proliferation and migration of vascular smooth muscle cells through the focal adhesion kinase, MAPK and STAT3 Tyr<sup>705</sup> signalling pathways.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI<sub>2</sub> : a safer alternative to COX-2 inhibition.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?
- Published in:
- 2017
- By:
- Publication type:
- journal article